4 Things to Know about Pancreatic Cancer

Illustration of human abdominal area with pancreas highlighted in red.

Pancreatic cancer is difficult to detect early and often has spread to nearby organs when it is diagnosed.


Pancreatic cancer currently has a grim prognosis. But there is good reason for optimism that the outlook will be brighter soon.

The announcement by Jeopardy! host Alex Trebek on March 6 that he has stage IV pancreatic cancer has many people asking questions about this disease and its prognosis. MSK surgeon-scientist Vinod Balachandran, who has a particular research interest in pancreatic cancer, studies personalized cancer vaccines and other immunotherapies to treat people with the disease. Here, he discusses current treatment options and the most promising research in the field.

Vinod P. Balachandran, MD

Vinod Balachandran

What is the outlook for someone diagnosed with pancreatic cancer?

Compared with most other cancers, pancreatic cancer has a less favorable prognosis. The five-year survival rate for people with all types of pancreatic cancer is approximately 9%. For someone diagnosed with stage IV pancreatic cancer — meaning the cancer has spread from the pancreas to other organs — the median survival time is approximately one year. Overall, pancreatic cancer remains one of the most difficult cancers to treat.

In fact, pancreatic cancer is expected to become the second leading cancer killer in the United States by 2025, second only to lung cancer. Other diseases such as breast cancer, prostate cancer, and colorectal cancers are far more common, but we have more-effective therapies for them. There could be a national pancreatic cancer crisis unless we find better treatments.

Back to top

What are some of the risk factors for developing pancreatic cancer?

The strongest risk factors for pancreatic cancer are smoking, obesity, and diabetes. You also are at a higher risk if you are older than 55 or if you are African American. You are at a much higher risk if you have a family history of pancreatic cancer, defined as two or more first-degree relatives [parents, siblings, or children] with pancreatic cancer.

Back to top

How is pancreatic cancer usually treated?

The mainstays of pancreatic cancer treatment are surgery, chemotherapy, and radiation. Patients have much better outcomes if we can remove the tumor with surgery. Most people, however, can’t have surgery because when they are diagnosed the disease has already spread outside of the pancreas into other organs such as the liver. Some newer treatments that have shown great success in other cancers, such as targeted therapies and immunotherapy, have not yet made significant inroads into pancreatic cancer care. But that is rapidly changing.

People today have many more options than they did ten years ago.
Vinod P. Balachandran
Vinod P. Balachandran surgeon-scientist
Back to top

What are some reasons to be optimistic about the future?

There has been great progress in pancreatic cancer research and treatment. First, we are getting significantly better at giving standard treatments. Last year, a study showed that a combination of four chemotherapy drugs given after surgery could extend overall survival to nearly five years. This applies only to a particular group of patients, but it might be possible to replicate this success for other groups.

We also are learning that targeted therapies could be helpful in subsets of people with pancreatic cancer. A class of drugs known as PARP inhibitors has shown promise in treating certain pancreatic tumors in people with inherited mutations in the BRCA genes. These are the same genes that have been linked to hereditary breast and ovarian cancer, and PARP inhibitors have shown they can be effective against these cancers.

The other new area of research is immunotherapy. So far, pancreatic cancers have been resistant to this form of treatment. But as we learn more about the molecular makeup of pancreatic cancers, it will help us to develop better immunotherapy approaches. For example, we have learned that people with pancreatic cancer whose tumors had a certain type of mutation called mismatch repair will respond to immunotherapy drugs called checkpoint inhibitors. The FDA approved a checkpoint inhibitor drug, pembrolizumab (Keytruda®), for patients with this mutation in 2017. Even though pembrolizumab has helped only a small fraction of people with pancreatic cancer, it proves that immunotherapy can actually work for this disease.

Overall, people today have many more options than they did ten years ago. Even if standard therapies stop working, there are more treatment choices and clinical trials available. For the first time in a long while, there is a real belief in the pancreatic cancer community that we can effectively treat this disease. But more research is needed to develop better treatments. Progress requires research.

Back to top


Dr. Balachandran, thanks for the explanation. My sister-in-law of 44 yr old was diagnosed with pancreatic cancer, spread already, but not to major organs. I have requested consultation on web, but would like to get your care. She is in China and we are in US.

Dear Danping, we’re very sorry to hear about your sister-in-law’s diagnosis. If she is interested in coming to MSK from China, we recommend that she contact our International Center at international@mskcc.org. Thank you for your comment and best wishes to you and your family.

Dear Team

My father passed away on the 4th of March : we only found out 3 weeks prior he had cancer ...

Unfortunately we were unable to determine what kind of cancer he had but what I do know is that he had 50 or more tumors in liver , cervical , thoracic and tale bone was compromised .

His father also passed away : cancer unknown ..Alledgedly he may have even passed at Sloan but we were estranged : hence why we don’t know .

Plus I have countless other relatives on my mothers side who passed : Colon, pancreatic ,prostate and lung.

I don’t want to feel like I’m a dead man walking ; how can I be proactive in my pursuit to be ahead of the cancer and not behind it

Dear Laura, we’re sorry to hear about your family history. If you would like to make an appointment to speak with one of our genetics counselors, you can contact our Clinical Genetics Service at 646-888-4050. Thank you for your comment and best wishes to you.

Add new comment

We welcome your questions and comments. While we share many of them with our world-class doctors and researchers, we regret that in order to protect your privacy, we are not able to make personal medical recommendations on this forum, nor do we publish comments that contain your personal information. If you would like to consult with an MSK doctor, we encourage you to make an appointment at 800-525-2225 or request an appointment online.

Your email address is kept private and will not be shown publicly.